Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A review on ferulic acid and analogs based scaffolds for the management of Alzheimer’s disease
Yash Pal Singh, Himanshu Rai, Gourav Singh, et al.
European Journal of Medicinal Chemistry (2021) Vol. 215, pp. 113278-113278
Closed Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Therapeutic Potential of Phenolic Compounds in Medicinal Plants—Natural Health Products for Human Health
Wenli Sun, Mohamad Hesam Shahrajabian
Molecules (2023) Vol. 28, Iss. 4, pp. 1845-1845
Open Access | Times Cited: 313
Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress
Zhipei Sang, Keren Wang, Jianghong Dong, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114464-114464
Closed Access | Times Cited: 88
Recent Advances in the Neuroprotective Properties of Ferulic Acid in Alzheimer’s Disease: A Narrative Review
Silvia Di Giacomo, Ester Percaccio, Marco Gullì, et al.
Nutrients (2022) Vol. 14, Iss. 18, pp. 3709-3709
Open Access | Times Cited: 41
Exploitation of the multitarget role of new ferulic and gallic acid derivatives in oxidative stress-related Alzheimer's disease therapies: design, synthesis and bioevaluation
Fahad Hussain, Ayesha Tahir, Muhammad Saeed Jan, et al.
RSC Advances (2024) Vol. 14, Iss. 15, pp. 10304-10321
Open Access | Times Cited: 9
Safety issues of donepezil combined with memantine in Alzheimer’s disease population: real-world pharmacovigilance
Yi Zeng, Bingshuo Liu, Lisi Zhou, et al.
Expert Opinion on Drug Safety (2025)
Closed Access | Times Cited: 1
Natural Products as Sources of Multitarget Compounds: Advances in the Development of Ferulic Acid as Multitarget Therapeutic
Rajwinder Kaur, Ankita Sood, Damanpreet Kaur Lang, et al.
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 5, pp. 347-365
Closed Access | Times Cited: 32
Medicine–food herb:Angelica sinensis, a potential therapeutic hope for Alzheimer's disease and related complications
Yu Long, Dan Li, Shuang Yu, et al.
Food & Function (2022) Vol. 13, Iss. 17, pp. 8783-8803
Closed Access | Times Cited: 30
Guanidine-based β amyloid precursor protein cleavage enzyme 1 (BACE-1) inhibitors for the Alzheimer's disease (AD): A review
Pinky Gehlot, Sunil Kumar, Vivek K. Vyas, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 74, pp. 117047-117047
Closed Access | Times Cited: 28
Ferulic acid-loaded polymeric nanoparticles prepared from nano-emulsion templates facilitate internalisation across the blood–brain barrier in model membranes
Luna Garcia, Sujey Palma-Florez, V. Espinosa, et al.
Nanoscale (2023) Vol. 15, Iss. 17, pp. 7929-7944
Open Access | Times Cited: 19
Molecular mechanisms underlying cyclophosphamide-induced cognitive impairment and strategies for neuroprotection in preclinical models
Kamilia M. Ibrahim, Samar F. Darwish, Eman M. Mantawy, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 8, pp. 1873-1893
Open Access | Times Cited: 19
Synthesis and evaluation of multitarget new 2‐aminothiazole derivatives as potential anti‐Alzheimer's agents
Merve Bardakkaya, Burcu Kılıç, Rahşan Ilıkçı Saǧkan, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 8
Open Access | Times Cited: 18
Molecular Targets of Valeric Acid: A Bioactive Natural Product for Endocrine, Metabolic, and Immunological Disorders
Bindu Kumari, Usha Kumari, D. K. Singh, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2024) Vol. 24, Iss. 13, pp. 1506-1517
Closed Access | Times Cited: 6
Ferulic acid’s therapeutic odyssey: nano formulations, pre-clinical investigations, and patent perspective
Sanshita, Monika Monika, Snigdha Chakraborty, et al.
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 3, pp. 479-493
Closed Access | Times Cited: 6
Dietary Phenolic Acids and Their Major Food Sources Are Associated with Cognitive Status in Older Italian Adults
Justyna Godos, Filippo Caraci, Agnieszka Micek, et al.
Antioxidants (2021) Vol. 10, Iss. 5, pp. 700-700
Open Access | Times Cited: 38
An overview of recent analysis and detection of acetylcholine
Xuan Gu, Xiaoying Wang
Analytical Biochemistry (2021) Vol. 632, pp. 114381-114381
Closed Access | Times Cited: 37
The Use of Bioactive Compounds in Hyperglycemia- and Amyloid Fibrils-Induced Toxicity in Type 2 Diabetes and Alzheimer’s Disease
Ancuța-Veronica Lupăescu, Monica Iavorschi, Mihai Covașă
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 235-235
Open Access | Times Cited: 23
Carbamate as a potential anti‐Alzheimer's pharmacophore: A review
Yash Pal Singh, Navneet Kumar, Brijesh Singh Chauhan, et al.
Drug Development Research (2023) Vol. 84, Iss. 8, pp. 1624-1651
Closed Access | Times Cited: 16
Nanotechnology-based gene therapy as a credible tool in the treatment of Alzheimer’s disease
NigelH Greig, Aziz Unnisa, MohammadAmjad Kamal
Neural Regeneration Research (2023) Vol. 18, Iss. 10, pp. 2127-2127
Open Access | Times Cited: 15
Design, Synthesis, and Biological Evaluation of Ferulic Acid Template-Based Novel Multifunctional Ligands Targeting NLRP3 Inflammasome for the Management of Alzheimer’s Disease
Gourav Singh, Gauri Shankar, Samir Ranjan Panda, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 7, pp. 1388-1414
Closed Access | Times Cited: 5
Recent Advances in Medicinal Chemistry of Memantine Against Alzheimer's Disease
Yash Pal Singh, Harish Kumar
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 4
Closed Access | Times Cited: 5
Hybrid Quinoline-Thiosemicarbazone Therapeutics as a New Treatment Opportunity for Alzheimer’s Disease‒Synthesis, In Vitro Cholinesterase Inhibitory Potential and Computational Modeling Analysis
Sumera Zaib, Rubina Munir, Muhammad Tayyab Younas, et al.
Molecules (2021) Vol. 26, Iss. 21, pp. 6573-6573
Open Access | Times Cited: 32
2-methylindole analogs as cholinesterases and glutathione S-transferase inhibitors: Synthesis, biological evaluation, molecular docking, and pharmacokinetic studies
Adnan Çetin, Ercan Bursal, Fikret Türkan
Arabian Journal of Chemistry (2021) Vol. 14, Iss. 12, pp. 103449-103449
Open Access | Times Cited: 30
Ferulic acid and vinpocetine intake improves memory function by enhancing insulin sensitivity and reducing neuroinflammation and oxidative stress in type 2 diabetic animals with induced Alzheimer's disease
Sunmin Park, Na Rang Moon, Suna Kang, et al.
Journal of Functional Foods (2022) Vol. 95, pp. 105180-105180
Open Access | Times Cited: 22
Medicine-Food Herbs against Alzheimer’s Disease: A Review of Their Traditional Functional Features, Substance Basis, Clinical Practices and Mechanisms of Action
Pengfei Guo, Baoyue Zhang, Jun Zhao, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 901-901
Open Access | Times Cited: 19
Ferulic Acid as a Protective Antioxidant of Human Intestinal Epithelial Cells
Hye-Jeong Hwang, So Rok Lee, Ju-Gyeong Yoon, et al.
Antioxidants (2022) Vol. 11, Iss. 8, pp. 1448-1448
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top